1 Colorectal Cancer Drugs Market Overview 1.1 Colorectal Cancer Drugs Product Overview 1.2 Colorectal Cancer Drugs Market Segment 1.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors 1.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitors 1.2.3 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors 1.2.4 BRAF or MEK Inhibitors 1.2.5 Tyrosine Kinase (TKI) Inhibitors 1.2.6 Immunomodulators 1.3 Global Colorectal Cancer Drugs Market Size 1.3.1 Global Colorectal Cancer Drugs Market Size Overview (2016-2027) 1.3.2 Global Colorectal Cancer Drugs Historic Market Size Review (2016-2021) 1.3.2.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume (2016-2021) 1.3.2.2 Global Colorectal Cancer Drugs Sales Breakdown in Value (2016-2021) 1.3.2.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2016-2021) 1.3.3 Global Colorectal Cancer Drugs Forecasted Market Size (2022-2027) 1.3.3.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume (2022-2027) 1.3.3.2 Global Colorectal Cancer Drugs Sales Breakdown in Value (2022-2027) 1.3.3.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2022-2027) 1.4 Key Regions Market Size Segment 1.4.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021) 1.4.2 Europe Colorectal Cancer Drugs Sales Breakdown (2016-2021) 1.4.3 Asia-Pacific Colorectal Cancer Drugs Sales Breakdown (2016-2021) 1.4.4 Latin America Colorectal Cancer Drugs Sales Breakdown (2016-2021) 1.4.5 Middle East and Africa Colorectal Cancer Drugs Sales Breakdown (2016-2021) 2 Global Colorectal Cancer Drugs Market Competition by Company 2.1 Global Top Players by Colorectal Cancer Drugs Sales (2016-2021) 2.2 Global Top Players by Colorectal Cancer Drugs Revenue (2016-2021) 2.3 Global Top Players Colorectal Cancer Drugs Price (2016-2021) 2.4 Global Top Manufacturers Colorectal Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Type 2.5 Colorectal Cancer Drugs Market Competitive Situation and Trends 2.5.1 Colorectal Cancer Drugs Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Colorectal Cancer Drugs Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2020) 2.7 Date of Key Manufacturers Enter into Colorectal Cancer Drugs Market 2.8 Key Manufacturers Colorectal Cancer Drugs Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Colorectal Cancer Drugs Status and Outlook by Region 3.1 Global Colorectal Cancer Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Colorectal Cancer Drugs Historic Market Size by Region 3.2.1 Global Colorectal Cancer Drugs Sales in Volume by Region (2016-2021) 3.2.2 Global Colorectal Cancer Drugs Sales in Value by Region (2016-2021) 3.2.3 Global Colorectal Cancer Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Colorectal Cancer Drugs Forecasted Market Size by Region 3.3.1 Global Colorectal Cancer Drugs Sales in Volume by Region (2022-2027) 3.3.2 Global Colorectal Cancer Drugs Sales in Value by Region (2022-2027) 3.3.3 Global Colorectal Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Colorectal Cancer Drugs 4.1 Colorectal Cancer Drugs Market Segment 4.1.1 Radiotherapy 4.1.2 Chemotherapy 4.2 Global Colorectal Cancer Drugs Market Size 4.2.1 Global Colorectal Cancer Drugs Market Size Overview (2016-2027) 4.2.2 Global Colorectal Cancer Drugs Historic Market Size Review (2016-2021) 4.2.2.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume, (2016-2021) 4.2.2.2 Global Colorectal Cancer Drugs Sales Breakdown in Value, (2016-2021) 4.2.2.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2016-2021) 4.2.3 Global Colorectal Cancer Drugs Forecasted Market Size (2022-2027) 4.2.3.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume, (2022-2027) 4.2.3.2 Global Colorectal Cancer Drugs Sales Breakdown in Value, (2022-2027) 4.2.3.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2022-2027) 4.3 Key Regions Market Size Segment 4.3.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021) 4.3.2 Europe Colorectal Cancer Drugs Sales Breakdown (2016-2021) 4.3.3 Asia-Pacific Colorectal Cancer Drugs Sales Breakdown (2016-2021) 4.3.4 Latin America Colorectal Cancer Drugs Sales Breakdown (2016-2021) 4.3.5 Middle East and Africa Colorectal Cancer Drugs Sales Breakdown (2016-2021) 5 North America Colorectal Cancer Drugs by Country 5.1 North America Colorectal Cancer Drugs Historic Market Size by Country 5.1.1 North America Colorectal Cancer Drugs Sales in Volume by Country (2016-2021) 5.1.2 North America Colorectal Cancer Drugs Sales in Value by Country (2016-2021) 5.2 North America Colorectal Cancer Drugs Forecasted Market Size by Country 5.2.1 North America Colorectal Cancer Drugs Sales in Volume by Country (2022-2027) 5.2.2 North America Colorectal Cancer Drugs Sales in Value by Country (2022-2027) 6 Europe Colorectal Cancer Drugs by Country 6.1 Europe Colorectal Cancer Drugs Historic Market Size by Country 6.1.1 Europe Colorectal Cancer Drugs Sales in Volume by Country (2016-2021) 6.1.2 Europe Colorectal Cancer Drugs Sales in Value by Country (2016-2021) 6.2 Europe Colorectal Cancer Drugs Forecasted Market Size by Country 6.2.1 Europe Colorectal Cancer Drugs Sales in Volume by Country (2022-2027) 6.2.2 Europe Colorectal Cancer Drugs Sales in Value by Country (2022-2027) 7 Asia-Pacific Colorectal Cancer Drugs by Region 7.1 Asia-Pacific Colorectal Cancer Drugs Historic Market Size by Region 7.1.1 Asia-Pacific Colorectal Cancer Drugs Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Colorectal Cancer Drugs Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Colorectal Cancer Drugs Forecasted Market Size by Region 7.2.1 Asia-Pacific Colorectal Cancer Drugs Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Colorectal Cancer Drugs Sales in Value by Region (2022-2027) 8 Latin America Colorectal Cancer Drugs by Country 8.1 Latin America Colorectal Cancer Drugs Historic Market Size by Country 8.1.1 Latin America Colorectal Cancer Drugs Sales in Volume by Country (2016-2021) 8.1.2 Latin America Colorectal Cancer Drugs Sales in Value by Country (2016-2021) 8.2 Latin America Colorectal Cancer Drugs Forecasted Market Size by Country 8.2.1 Latin America Colorectal Cancer Drugs Sales in Volume by Country (2022-2027) 8.2.2 Latin America Colorectal Cancer Drugs Sales in Value by Country (2022-2027) 9 Middle East and Africa Colorectal Cancer Drugs by Country 9.1 Middle East and Africa Colorectal Cancer Drugs Historic Market Size by Country 9.1.1 Middle East and Africa Colorectal Cancer Drugs Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Colorectal Cancer Drugs Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Colorectal Cancer Drugs Forecasted Market Size by Country 9.2.1 Middle East and Africa Colorectal Cancer Drugs Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Colorectal Cancer Drugs Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Colorectal Cancer Drugs Business 10.1 AB Science 10.1.1 AB Science Corporation Information 10.1.2 AB Science Introduction and Business Overview 10.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.1.4 AB Science Colorectal Cancer Drugs Products Offered 10.1.5 AB Science Recent Development 10.2 Amgen 10.2.1 Amgen Corporation Information 10.2.2 Amgen Introduction and Business Overview 10.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.2.4 AB Science Colorectal Cancer Drugs Products Offered 10.2.5 Amgen Recent Development 10.3 Array BioPharma 10.3.1 Array BioPharma Corporation Information 10.3.2 Array BioPharma Introduction and Business Overview 10.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered 10.3.5 Array BioPharma Recent Development 10.4 Bayer 10.4.1 Bayer Corporation Information 10.4.2 Bayer Introduction and Business Overview 10.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Bayer Colorectal Cancer Drugs Products Offered 10.4.5 Bayer Recent Development 10.5 Boehringer Ingelheim 10.5.1 Boehringer Ingelheim Corporation Information 10.5.2 Boehringer Ingelheim Introduction and Business Overview 10.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered 10.5.5 Boehringer Ingelheim Recent Development 10.6 Bristol-Myers Squibb 10.6.1 Bristol-Myers Squibb Corporation Information 10.6.2 Bristol-Myers Squibb Introduction and Business Overview 10.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered 10.6.5 Bristol-Myers Squibb Recent Development 10.7 Elli Lilly 10.7.1 Elli Lilly Corporation Information 10.7.2 Elli Lilly Introduction and Business Overview 10.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered 10.7.5 Elli Lilly Recent Development 10.8 Roch 10.8.1 Roch Corporation Information 10.8.2 Roch Introduction and Business Overview 10.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Roch Colorectal Cancer Drugs Products Offered 10.8.5 Roch Recent Development 10.9 Hutchison MediPharma 10.9.1 Hutchison MediPharma Corporation Information 10.9.2 Hutchison MediPharma Introduction and Business Overview 10.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered 10.9.5 Hutchison MediPharma Recent Development 10.10 Merck & Co., Inc. 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Colorectal Cancer Drugs Product Category, Application and Specification 10.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Merck & Co., Inc. Recent Development 10.11 Mologen 10.11.1 Mologen Corporation Information 10.11.2 Mologen Introduction and Business Overview 10.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Mologen Colorectal Cancer Drugs Products Offered 10.11.5 Mologen Recent Development 10.12 Regeneron 10.12.1 Regeneron Corporation Information 10.12.2 Regeneron Introduction and Business Overview 10.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Regeneron Colorectal Cancer Drugs Products Offered 10.12.5 Regeneron Recent Development 10.13 Sanofi 10.13.1 Sanofi Corporation Information 10.13.2 Sanofi Introduction and Business Overview 10.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Sanofi Colorectal Cancer Drugs Products Offered 10.13.5 Sanofi Recent Development 10.14 Sumitomo Dainippon 10.14.1 Sumitomo Dainippon Corporation Information 10.14.2 Sumitomo Dainippon Introduction and Business Overview 10.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Products Offered 10.14.5 Sumitomo Dainippon Recent Development 10.15 Taiho Pharmaceutical 10.15.1 Taiho Pharmaceutical Corporation Information 10.15.2 Taiho Pharmaceutical Introduction and Business Overview 10.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Products Offered 10.15.5 Taiho Pharmaceutical Recent Development 10.16 Vaccinogen 10.16.1 Vaccinogen Corporation Information 10.16.2 Vaccinogen Introduction and Business Overview 10.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.16.4 Vaccinogen Colorectal Cancer Drugs Products Offered 10.16.5 Vaccinogen Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Colorectal Cancer Drugs Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Colorectal Cancer Drugs Industrial Chain Analysis 11.4 Colorectal Cancer Drugs Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Colorectal Cancer Drugs Distributors 12.3 Colorectal Cancer Drugs Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Vascular Endothelial Growth Factor (VEGF) Inhibitors Table 2. Major Company of Epidermal Growth Factor Receptor (EGFR) Inhibitors Table 3. Major Company of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Table 4. Major Company of BRAF or MEK Inhibitors Table 5. Major Company of Tyrosine Kinase (TKI) Inhibitors Table 6. Major Company of Immunomodulators Table 7. Global Colorectal Cancer Drugs Sales 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Colorectal Cancer Drugs Sales (2016-2021) & (MT) Table 9. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021) Table 10. Global Colorectal Cancer Drugs Sales (2016-2021) & (US& Million) Table 11. Global Colorectal Cancer Drugs Market Share in Value (2016-2021) Table 12. Global Colorectal Cancer Drugs Price (2016-2021) & (USD/Kg) Table 13. Global Colorectal Cancer Drugs Sales (2022-2027) & (MT) Table 14. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027) Table 15. Global Colorectal Cancer Drugs Sales (2022-2027) & (US$ Million) Table 16. Global Colorectal Cancer Drugs Sales Market Share in Value (2022-2027) Table 17. Global Colorectal Cancer Drugs Price (2022-2027) & (USD/Kg) Table 18. North America Colorectal Cancer Drugs Sales (2016-2021) & (MT) Table 19. North America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 20. Europe Colorectal Cancer Drugs Sales (MT) (2016-2021) Table 21. Europe Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 22. Asia-Pacific Colorectal Cancer Drugs Sales (MT) (2016-2021) Table 23. Asia-Pacific Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 24. Latin America Colorectal Cancer Drugs Sales (MT) (2016-2021) Table 25. Latin America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 26. Middle East and Africa Colorectal Cancer Drugs Sales (MT) (2016-2021) Table 27. Middle East and Africa Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 28. Global Colorectal Cancer Drugs Sales by Company (2016-2021) & (MT) Table 29. Global Colorectal Cancer Drugs Sales Share by Company (2016-2021) Table 30. Global Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million) Table 31. Global Colorectal Cancer Drugs Revenue Share by Company (2016-2021) Table 32. Global Market Colorectal Cancer Drugs Price by Company (2016-2021) & (USD/Kg) Table 33. Global Colorectal Cancer Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area Table 34. Global Colorectal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2020 Table 36. Date of Key Manufacturers Enter into Colorectal Cancer Drugs Market Table 37. Key Manufacturers Colorectal Cancer Drugs Product Type Table 38. Mergers & Acquisitions, Expansion Plans Table 39. Global Colorectal Cancer Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 40. Global Colorectal Cancer Drugs Sales by Region (2016-2021) & (MT) Table 41. Global Colorectal Cancer Drugs Sales Market Share in Volume by Region (2016-2021) Table 42. Global Colorectal Cancer Drugs Sales by Region (2016-2021) & (US$ Million) Table 43. Global Colorectal Cancer Drugs Sales Market Share in Value by Region (2016-2021) Table 44. Global Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 45. Global Colorectal Cancer Drugs Sales by Region (2022-2027) & (MT) Table 46. Global Colorectal Cancer Drugs Sales Market Share in Volume by Region (2022-2027) Table 47. Global Colorectal Cancer Drugs Sales by Region (2022-2027) & (US$ Million) Table 48. Global Colorectal Cancer Drugs Sales Market Share in Value by Region (2022-2027) Table 49. Global Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2022-2027) Table 50. Global Colorectal Cancer Drugs Sales : 2016 VS 2021 VS 2027 (US$ Million) Table 51. Global Colorectal Cancer Drugs Sales (2016-2021) & (MT) Table 52. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021) Table 53. Global Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 54. Global Colorectal Cancer Drugs Sales Market Share in Value (2016-2021) Table 55. Global Colorectal Cancer Drugs Price (2016-2021) & (USD/Kg) Table 56. Global Colorectal Cancer Drugs Sales (2022-2027) & (MT) Table 57. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027) Table 58. Global Colorectal Cancer Drugs Sales (2022-2027) & (US$ Million) Table 59. Global Colorectal Cancer Drugs Sales Market Share in Value (2022-2027) Table 60. Global Colorectal Cancer Drugs Price (2022-2027) & (USD/Kg) Table 61. North America Colorectal Cancer Drugs Sales (2016-2021) (MT) Table 62. North America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 63. North America Colorectal Cancer Drugs Sales Market Share in Value in 2020 Table 64. Europe Colorectal Cancer Drugs Sales (2016-2021) (MT) Table 65. Europe Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 66. Europe Colorectal Cancer Drugs Sales Market Share in Value in 2020 Table 67. Asia-Pacific Colorectal Cancer Drugs Sales (2016-2021) (MT) Table 68. Asia-Pacific Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 69. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value in 2020 Table 70. Latin America Colorectal Cancer Drugs Sales (2016-2021) (MT) Table 71. Latin America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 72. Latin America Colorectal Cancer Drugs Sales Market Share in Value in 2020 Table 73. Middle East and Africa Colorectal Cancer Drugs Sales (2016-2021) (MT) Table 74. Middle East and Africa Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million) Table 75. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value in 2020 Table 76. North America Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT) Table 77. North America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 78. North America Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 79. North America Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021) Table 80. North America Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT) Table 81. North America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 82. North America Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 83. North America Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027) Table 84. Europe Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT) Table 85. Europe Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 86. Europe Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 87. Europe Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021) Table 88. Europe Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT) Table 89. Europe Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 90. Europe Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 91. Europe Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027) Table 92. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2016-2021) & (MT) Table 93. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Volume by Region (2016-2021) Table 94. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2016-2021) & (US$ Million) Table 95. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value by Region (2016-2021) Table 96. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2022-2027) & (MT) Table 97. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Volume by Region (2022-2027) Table 98. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2022-2027) & (US$ Million) Table 99. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value by Region (2022-2027) Table 100. Latin America Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT) Table 101. Latin America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 102. Latin America Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 103. Latin America Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021) Table 104. Latin America Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT) Table 105. Latin America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 106. Latin America Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 107. Latin America Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027) Table 108. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT) Table 109. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 110. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 111. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021) Table 112. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT) Table 113. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 114. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 115. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027) Table 116. AB Science Corporation Information Table 117. AB Science Introduction and Business Overview Table 118. AB Science Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 119. AB Science Colorectal Cancer Drugs Product Table 120. AB Science Recent Development Table 121. Amgen Corporation Information Table 122. Amgen Introduction and Business Overview Table 123. Amgen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 124. Amgen Colorectal Cancer Drugs Product Table 125. Amgen Recent Development Table 126. Array BioPharma Corporation Information Table 127. Array BioPharma Introduction and Business Overview Table 128. Array BioPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 129. Array BioPharma Colorectal Cancer Drugs Product Table 130. Array BioPharma Recent Development Table 131. Bayer Corporation Information Table 132. Bayer Introduction and Business Overview Table 133. Bayer Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 134. Bayer Colorectal Cancer Drugs Product Table 135. Bayer Recent Development Table 136. Boehringer Ingelheim Corporation Information Table 137. Boehringer Ingelheim Introduction and Business Overview Table 138. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 139. Boehringer Ingelheim Colorectal Cancer Drugs Product Table 140. Boehringer Ingelheim Recent Development Table 141. Bristol-Myers Squibb Corporation Information Table 142. Bristol-Myers Squibb Introduction and Business Overview Table 143. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 144. Bristol-Myers Squibb Colorectal Cancer Drugs Product Table 145. Bristol-Myers Squibb Recent Development Table 146. Elli Lilly Corporation Information Table 147. Elli Lilly Introduction and Business Overview Table 148. Elli Lilly Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 149. Elli Lilly Colorectal Cancer Drugs Product Table 150. Elli Lilly Recent Development Table 151. Roch Corporation Information Table 152. Roch Introduction and Business Overview Table 153. Roch Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 154. Roch Colorectal Cancer Drugs Product Table 155. Roch Recent Development Table 156. Hutchison MediPharma Corporation Information Table 157. Hutchison MediPharma Introduction and Business Overview Table 158. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 159. Hutchison MediPharma Colorectal Cancer Drugs Product Table 160. Hutchison MediPharma Recent Development Table 161. Merck & Co., Inc. Corporation Information Table 162. Merck & Co., Inc. Introduction and Business Overview Table 163. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 164. Merck & Co., Inc. Colorectal Cancer Drugs Product Table 165. Merck & Co., Inc. Recent Development Table 166. Mologen Corporation Information Table 167. Mologen Introduction and Business Overview Table 168. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 169. Mologen Colorectal Cancer Drugs Product Table 170. Mologen Recent Development Table 171. Regeneron Corporation Information Table 172. Regeneron Introduction and Business Overview Table 173. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 174. Regeneron Colorectal Cancer Drugs Product Table 175. Regeneron Recent Development Table 176. Sanofi Corporation Information Table 177. Sanofi Introduction and Business Overview Table 178. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 179. Sanofi Colorectal Cancer Drugs Product Table 180. Sanofi Recent Development Table 181. Sumitomo Dainippon Corporation Information Table 182. Sumitomo Dainippon Introduction and Business Overview Table 183. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 184. Sumitomo Dainippon Colorectal Cancer Drugs Product Table 185. Sumitomo Dainippon Recent Development Table 186. Taiho Pharmaceutical Corporation Information Table 187. Taiho Pharmaceutical Introduction and Business Overview Table 188. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 189. Taiho Pharmaceutical Colorectal Cancer Drugs Product Table 190. Taiho Pharmaceutical Recent Development Table 191. Vaccinogen Corporation Information Table 192. Vaccinogen Introduction and Business Overview Table 193. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 194. Vaccinogen Colorectal Cancer Drugs Product Table 195. Vaccinogen Recent Development Table 196. Key Raw Materials Lists Table 197. Raw Materials Key Suppliers Lists Table 198. Colorectal Cancer Drugs Market Trends Table 199. Colorectal Cancer Drugs Market Drivers Table 200. Colorectal Cancer Drugs Market Challenges Table 201. Colorectal Cancer Drugs Market Restraints Table 202. Colorectal Cancer Drugs Distributors List Table 203. Colorectal Cancer Drugs Downstream Customers Table 204. Research Programs/Design for This Report Table 205. Key Data Information from Secondary Sources Table 206. Key Data Information from Primary Sources List of Figures Figure 1. Colorectal Cancer Drugs Product Picture Figure 2. Global Colorectal Cancer Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Colorectal Cancer Drugs Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Colorectal Cancer Drugs Sales Status and Outlook (2016-2027) & (MT) Figure 5. Product Picture of Vascular Endothelial Growth Factor (VEGF) Inhibitors Figure 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales YoY Growth (2016-2021) & (MT) Figure 7. Product Picture of Epidermal Growth Factor Receptor (EGFR) Inhibitors Figure 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Sales YoY Growth (2016-2021) & (MT) Figure 9. Product Picture of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Figure 10. Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Sales YoY Growth (2016-2021) & (MT) Figure 11. Product Picture of BRAF or MEK Inhibitors Figure 12. Global BRAF or MEK Inhibitors Sales YoY Growth (2016-2021) & (MT) Figure 13. Product Picture of Tyrosine Kinase (TKI) Inhibitors Figure 14. Global Tyrosine Kinase (TKI) Inhibitors Sales YoY Growth (2016-2021) & (MT) Figure 15. Product Picture of Immunomodulators Figure 16. Global Immunomodulators Sales YoY Growth (2016-2021) & (MT) Figure 17. Global Colorectal Cancer Drugs Sales (2016-2027) & (US$ Million) Figure 18. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021) Figure 19. Global Colorectal Cancer Drugs Sales Market Share in Value (2016-2021) Figure 20. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027) Figure 21. Global Colorectal Cancer Drugs Sales Market Share in Value (2022-2027) Figure 22. North America Colorectal Cancer Drugs Sales Market Share in Volume in 2020 Figure 23. North America Colorectal Cancer Drugs Sales Market Share in Value in 2020 Figure 24. Europe Colorectal Cancer Drugs Sales Market Share in Volume in 2020 Figure 25. Europe Colorectal Cancer Drugs Sales Market Share in Value in 2020 Figure 26. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Volume in 2020 Figure 27. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value in 2020 Figure 28. Latin America Colorectal Cancer Drugs Sales Market Share in Volume in 2020 Figure 29. Latin America Colorectal Cancer Drugs Sales Market Share in Value in 2020 Figure 30. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Volume in 2020 Figure 31. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value in 2020 Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Colorectal Cancer Drugs Sales in 2020 Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Colorectal Cancer Drugs Revenue in 2020 Figure 34. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 35. Product Picture of Radiotherapy Figure 36. Global Radiotherapy Sales YoY Growth (2016-2027) & (MT) Figure 37. Product Picture of Chemotherapy Figure 38. Global Chemotherapy Sales YoY Growth (2016-2027) & (MT) Figure 39. Global Colorectal Cancer Drugs Sales (2016-2027) & (US$ Million) Figure 40. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021) Figure 41. Global Colorectal Cancer Drugs Sales Market Share in Value (2016-2021) Figure 42. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027) Figure 43. North America Colorectal Cancer Drugs Sales Market Share in Volume in 2020 Figure 44. Latin America Colorectal Cancer Drugs Sales Market Share in Value in 2020 Figure 45. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value in 2020 Figure 46. Key Raw Materials Price Figure 47. Colorectal Cancer Drugs Manufacturing Cost Structure Figure 48. Colorectal Cancer Drugs Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

AB Science Amgen Array BioPharma Bayer Boehringer Ingelheim Bristol-Myers Squibb Elli Lilly Roch Hutchison MediPharma Merck & Co., Inc. Mologen Regeneron Sanofi Sumitomo Dainippon Taiho Pharmaceutical Vaccinogen